Current Drug Targets
Title:Meet Our Editorial Board Member
Volume: 22 Issue: 7
Author(s): S. Lee
Affiliation:
Export Options
About this article
Cite this article as:
Lee S. , Meet Our Editorial Board Member, Current Drug Targets 2021; 22 (7) . https://dx.doi.org/10.2174/138945012207210316111310
DOI https://dx.doi.org/10.2174/138945012207210316111310 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis and Evaluation of Tricyclic Dipyrido Diazepinone Derivatives as Inhibitors of Secretory Phospholipase A2 with Anti-Inflammatory Activity
Current Topics in Medicinal Chemistry Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B
Current Medicinal Chemistry Controlled Somatic and Germline Copy Number Variation in the Mouse Model
Current Genomics Perforated One Anastomosis Gastric Bypass, How we Managed and Review of Literature
New Emirates Medical Journal Niacin: From Mechanisms of Action to Therapeutic Uses
Mini-Reviews in Medicinal Chemistry Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells
Current Pharmaceutical Design DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives
Current Clinical Pharmacology NAP (Davunetide) Provides Functional and Structural Neuroprotection
Current Pharmaceutical Design Subject Index to Volume 1
Current Pharmacogenomics Current status of Immunotherapy in B Cell Malignancies
Current Drug Targets Albumin Induces Neuroprotection Against Ischemic Stroke by Altering Toll-Like Receptor 4 and Regulatory T Cells in Mice
CNS & Neurological Disorders - Drug Targets Human Stem Cells and Articular Cartilage Tissue Engineering
Current Pharmaceutical Biotechnology Possible Mechanisms Explaining the Association between Zika Virus and Guillain-barre Syndrome: An Immunological Approach
Current Immunology Reviews (Discontinued) Essentials in the Treatment of COVID-19
Anti-Infective Agents Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy
Current Molecular Pharmacology Airway Clearance of Apoptotic Cells in COPD
Current Drug Targets Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review
Current Drug Targets General Aspects of Metal Toxicity
Current Medicinal Chemistry Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD
Current Medicinal Chemistry